title: [Prostate bed radiotherapy--when and what?].
abstract: BACKGROUND
  Recently, prostate bed irradiation has, due to the results of randomized trials which confirmed its benefit in adjuvant treatment, become the standard treatment for patients with risk factors after radical prostatectomy. It is also irreplaceable in the treatment of biochemical progression caused by local recurrence. In most cases, the tumour is not visible on planning CT, so it is necessary to use all available information to define the target volume to treat all the sites where the recurrence could be present.
  
  
  METHODS
  The aim of this review is to provide a compendium of radiotherapy after radical prostatectomy, its indications and especially the localization of recurrences, which implicates the clinical target volume definitions.
  
  
  CONCLUSIONS
  The treatment of prostate cancer requires close co-operation between urologists and radiation oncologists, especially now when the indication of radiotherapy includes patients with risk factors after radical prostatectomy where adjuvant treatment should be performed early after surgery. It is of the utmost importance to precisely define the target volume for radiotherapy to fully prevent local recurrence without unnecessary complications for the patient.
authors.affiliation: Klinika onkologie a radioterapie, FN Hradec Králové, Sokolská 581, 500 05 Hradec Králové. sefrova@fnhk.cz
authors.forename: J
authors.initials: J
authors.lastname: Sefrová
authors.forename: K
authors.initials: K
authors.lastname: Odrázka
authors.forename: P
authors.initials: P
authors.lastname: Paluska
authors.forename: M
authors.initials: M
authors.lastname: Brod'ák
authors.forename: L
authors.initials: L
authors.lastname: Rousková
mesh_terms: D006801:Humans; D008297:Male; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D018714:Radiotherapy, Adjuvant